Jun 3, 2026 08:02AM
Jun 1, 2026 07:01AM
Apr 22, 2026 07:01AM
Apr 22, 2026 07:01AM
Dec 12, 2025 08:45AM
Dec 1, 2025 08:45AM
Oct 27, 2025 07:00AM ACTINIUM reports lung cancer drug data at medical conference
Oct 24, 2025 08:30AM
Jul 31, 2025 08:31AM
Jun 24, 2025 06:53AM
Jun 23, 2025 11:31AM
May 26, 2025 10:20AM
May 25, 2025 09:03AM
May 24, 2025 08:50AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium
May 22, 2025 04:00PM
May 21, 2025 09:53AM
May 19, 2025 06:40PM
May 17, 2025 08:03AM
May 16, 2025 04:00PM
May 15, 2025 10:20AM
May 12, 2025 05:48PM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium
May 11, 2025 04:00PM
May 10, 2025 08:04AM
May 5, 2025 04:00PM
May 5, 2025 10:11AM
May 2, 2025 10:19AM
Apr 29, 2025 04:00PM
Apr 28, 2025 08:36AM Actinium Pharma (ATNM) Presents Data Showing ATNM-400 is More Efficacious than Pluvicto and is Highly Efficacious after Pluvicto Resistance in Prostate Cancer Tumor Models
Apr 23, 2025 04:00PM
Apr 22, 2025 09:30AM
Apr 17, 2025 04:00PM
Apr 17, 2025 11:50AM
Apr 11, 2025 04:00PM
Apr 10, 2025 04:00PM
Apr 8, 2025 04:03PM Faruqi & Faruqi Reminds Actinium Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 26, 2025 - ATNM
Apr 7, 2025 06:13PM
Apr 6, 2025 04:00PM
Apr 5, 2025 03:15PM
Apr 4, 2025 03:10PM
Apr 2, 2025 02:15PM
Apr 1, 2025 08:30PM
Apr 1, 2025 12:35PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATNM
Apr 1, 2025 12:29PM
Mar 31, 2025 04:00PM
Mar 28, 2025 08:00PM
Mar 27, 2025 08:45AM
Mar 27, 2025 07:30AM
Mar 26, 2025 06:53AM
Mar 24, 2025 04:16PM Actinium Pharma (ATNM) Announces Supply Agreement with Eckert & Ziegler for Ac-225 Radioisotope to Support Comprehensive Development Activities
Mar 17, 2025 08:50AM

416,806 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All